INVO Fertility (IVF) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 | -3.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.87% |
| Jun 30, 2025 | -3.22% |
| Mar 31, 2025 | -2.84% |
| Dec 31, 2024 | -2.37% |
| Sep 30, 2024 | -21.37% |
| Jun 30, 2024 | 51.41% |
| Mar 31, 2024 | 47.03% |
| Dec 31, 2023 | 84.21% |
| Sep 30, 2023 | 93.87% |
| Jun 30, 2023 | 82.48% |
| Mar 31, 2023 | 55.51% |
| Dec 31, 2022 | 67.43% |
| Sep 30, 2022 | 68.39% |
| Jun 30, 2022 | 68.94% |
| Mar 31, 2022 | 81.93% |
| Dec 31, 2021 | 144.17% |
| Sep 30, 2021 | 281.04% |
| Jun 30, 2021 | 100.82% |
| Mar 31, 2021 | 102.14% |
| Dec 31, 2020 | 103.45% |
| Sep 30, 2020 | 89.00% |
| Jun 30, 2020 | 90.49% |
| Mar 31, 2020 | 91.96% |
| Dec 31, 2019 | 80.97% |
| Sep 30, 2019 | 128.61% |
| Sep 30, 2017 | 217.62% |
| Jun 30, 2017 | 100.12% |
| Mar 31, 2017 | 66.05% |
| Dec 31, 2016 | 47.44% |
| Sep 30, 2016 | 7.91% |
| Sep 30, 2014 | -69.99% |
| Jun 30, 2014 | -54.07% |
| Dec 31, 2013 | -41.47% |